BeOne Medicines (ONC) FCF Margin (2015 - 2026)
BeOne Medicines (ONC) reported FCF Margin of 10.45% for Q1 2026, up 1187.0% year-over-year from 0.81% in Q1 2025, and down 44.81% on a QoQ basis from 18.93% in Q4 2025.
BeOne Medicines (ONC) has 12 years of FCF Margin data on file, last reported at 10.45% in Q1 2026.
- Quarterly FCF Margin rose 1187.0% year-over-year to 10.45% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 19.44% (up 1373.0% YoY) and the FY2025 annual result came in at 17.63%, up 2316.0% from the prior year.
- FCF Margin retreated to 10.45% in Q1 2026 per ONC's latest filing, from 18.93% in the prior quarter.
- Across five years, FCF Margin topped out at 35.91% in Q4 2024 and bottomed at 172.99% in Q3 2022.
- The 5-year median for FCF Margin is 22.12% (2024), against an average of 45.54%.
- Peak annual rise in FCF Margin reached 18758 bps in 2022, while the deepest fall reached 21932 bps in 2022.
- Tracing ONC's FCF Margin over 5 years: stood at 115.64% in 2022, then grew by 8 bps to 106.54% in 2023, then surged by 134 bps to 35.91% in 2024, then slumped by 47 bps to 18.93% in 2025, then slumped by 45 bps to 10.45% in 2026.
- Per Business Quant, the three latest ONC FCF Margin figures stand at 10.45% (Q1 2026), 18.93% (Q4 2025), and 28.92% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | -3.98% |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 43.35% |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 23.53% |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 4.17% |
| 10 | BeOne Medicines | - | - | 1.35 Bn | 10.45% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.45% |
| Dec 31, 2025 | 18.93% |
| Sep 30, 2025 | 28.92% |
| Jun 30, 2025 | 20.20% |
| Mar 31, 2025 | -1.43% |
| Dec 31, 2024 | 35.91% |
| Sep 30, 2024 | 5.46% |
| Jun 30, 2024 | -22.12% |
| Mar 31, 2024 | -44.97% |
| Dec 31, 2023 | -106.54% |
| Sep 30, 2023 | 7.85% |
| Jun 30, 2023 | -80.12% |
| Mar 31, 2023 | -140.19% |
| Dec 31, 2022 | -115.64% |
| Sep 30, 2022 | -172.99% |
| Jun 30, 2022 | -125.96% |
| Mar 31, 2022 | -91.87% |
| Dec 31, 2021 | 103.68% |
| Sep 30, 2021 | -272.60% |
| Jun 30, 2021 | -313.54% |
| Mar 31, 2021 | 15.55% |
| Dec 31, 2020 | -418.50% |
| Sep 30, 2020 | -382.31% |
| Jun 30, 2020 | -411.93% |
| Mar 31, 2020 | -698.20% |
| Dec 31, 2019 | -575.72% |
| Sep 30, 2019 | -515.23% |
| Jun 30, 2019 | -40.13% |
| Mar 31, 2019 | -249.00% |
| Dec 31, 2018 | -288.00% |
| Sep 30, 2018 | -315.87% |
| Jun 30, 2018 | -218.63% |
| Mar 31, 2018 | -350.90% |
| Dec 31, 2017 | 654.64% |
| Sep 30, 2017 | -5.43% |
| Jun 30, 2016 | -6,287.79% |
| Mar 31, 2016 | -3,418.61% |
| Dec 31, 2015 | -318.43% |
| Sep 30, 2015 | -850.36% |
| Jun 30, 2015 | -456.16% |
| Mar 31, 2015 | -503.48% |